Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review
- PMID: 32607690
- PMCID: PMC7326306
- DOI: 10.1007/s11481-020-09940-9
Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review
Comment on
-
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.Lancet. 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6. Online ahead of print. Lancet. 2020. Retraction in: Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Retraction in: Lancet. 2020 Jul 18;396(10245):e2-e3. doi: 10.1016/S0140-6736(20)31528-2. PMID: 32450107 Free PMC article. Retracted.
References
-
- Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020a) Retraction- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. [published online ahead of print, 2020 May 22] [retracted in: Lancet. 2020 Jun 5;:null]. Lancet. S0140-6736(20)31180–31186. 10.1016/S0140-6736(20)31180-6
-
- Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN (2020b) Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 10.1056/NEJMoa2007621 [published online ahead of print, 2020 Jun 4] [retraction of: N Engl J Med. 2020 May 1;:]. N Engl J Med. NEJMc2021225. 10.1056/NEJMc2021225 - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources